Table 3.

Subgroup Analysis of SVR12 Rates and Virologic Failure

	Genotype 2(N = 23)	Genotype 3(N = 24)	Total (N = 47)
Overall SVR12 n/N (%)	22/23 (96)	20/24 (83)	42/47 (89)
95% CI	[78-100]	[63-95]	[77-97]
Age at baseline (years)
<50	2/2 (100)	8/8 (100)	10/10 (100)
95% CI	[16-100]	[63-100]	[69-100]
≥50	20/21 (95)	12/16 (75)	32/37 (87)
95% CI	[76-100]	[48-93]	[71-96]
Sex
Male	14/14 (100)	14/18 (78)	28/32 (88)
95% CI	[77-100]	[52-94]	[71-97]
Female	8/9 (89)	6/6 (100)	14/15 (93)
95% CI	[52-100]	[54-100]	[68-100]
Race
Black	0/0	1/1 (100)	1/1 (100)
95% CI (%)		[3-100]	[3-100]
Non-Black	22/23 (96)	19/23 (83)	41/46 (89)
95% CI	[78-100]	[61-95]	[76-96]
Ethnicity
Hispanic or Latino	10/11 (91)	9/10 (90)	19/21 (91)
95% CI	[59-100]	[56-100]	[70-99]
Not Hispanic or Latino	12/12 (100)	11/14 (79)	23/26 (89)
95% CI	[74-100]	[49-95]	[70-98]
Cirrhosis
No	9/9 (100)	10/12 (83)	19/21 (91)
95% CI	[66-100]	[52-98]	[70-99]
Yes	13/14 (93)	10/12 (83)	23/26 (89)
95% CI	[66-100]	[52-98]	[70-98]
Baseline HCV RNA
<6 log10 IU/mL	4/4 (100)	11/13 (85)	15/17 (88)
95% CI	[40-100]	[55-98]	[64-99]
≥6 log10 IU/mL	18/19 (95)	9/11 (82)	27/30 (90)
95% CI	[74-100]	[48-98]	[74-98]